Trials / Completed
CompletedNCT06653361
Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Hayatabad Medical Complex · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Proliferative diabetic retinopathy is a vision-threatening disease that can lead to irreversible visual loss. The treatment options for proliferative diabetic retinopathy are anti-VEGF injection and retinal photocoagulation. The study aims to compare ultra-widefield fluorescein angiography-based targeted retinal photocoagulation and panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Green laser | Green Laser |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2024-02-28
- Completion
- 2024-02-28
- First posted
- 2024-10-22
- Last updated
- 2024-10-23
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06653361. Inclusion in this directory is not an endorsement.